Maloloy-on, Harry .

HRN: 21-12-31  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/26/2022
CEFUROXIME 500MG (TAB)
11/26/2022
12/03/2022
ORAL
500mg
BID
AGE
Waiting Final Action 

Indication:  Empiric Then Culture-directed    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: